Predictive Models of Treatment Responses and Survival Outcomes in Patients With Soft Tissue Sarcoma

NCT05171413 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 800

Last updated 2021-12-28

No results posted yet for this study

Summary

The aim of this study was to developed and validated models to predict therapeutic responses and patients' survivals in patients with soft tissue sarcoma and compared these models with currently available models.

Conditions

  • Soft Tissue Sarcoma

Interventions

OTHER

Prediction model

We develop and validate clinical models to predict treatment responses and survival outcomes in patients with biopsy-proven with soft tissue sarcoma.

Sponsors & Collaborators

  • West China Hospital

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-01-01
Primary Completion
2024-12-31
Completion
2024-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05171413 on ClinicalTrials.gov